Access for Life provides solutions for chronic disease patients, adults and pediatrics, who require repetitive vascular access in hemodialysis, chemotherapy, blood disorders, and digestive disorders. These disease patients frequently require repetitive vein wall puncturing to implement therapy. The JEM series of smart devices are insertedsubcutaneously to the outside of a vein, fistula or graft, just beneath the skin. Their design and technology ensure repetitive vessel puncturing in the exact same spot. JEM’s attachment and internal design will prevent hematomas, thromboses and stenosis. JEM is projected to reduce the rate of clinical complications and reduce patient morbidity and mortality by providing safer venous access, while lowering healthcare costs. Particularly in dialysis patients who require repetitive access to fistulas where damage from pseudoaneurysms and hematomas may lead to increased morbidity and mortality. Access for Life's JEM patented chamber, affixed to the vessel wall, will avoid these complications and in cancer patients, its placement on an upper arm vein avoids chest wall complications. It's suitable for all vascular access patients.

Biotechnology

Health Care

Access for Life

Access for Life's headquarters in Fleetwood, PA, United States

Access for Life

Org chart

Teams

Offices

Similar companies